G01N 2800/32
Cardiovascular disorders
G01N2800/32 (Cardiovascular disorders) appears on 1,334 US grants and 2,614 published applications in this corpus.
Search patents in G01N- Granted patents
- 1,334
- Published applications
- 2,614
- Assignees
- 1,099
- Inventors
- 4,176
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 6 | 0 |
| 1996 | 2 | 0 |
| 1997 | 5 | 0 |
| 1998 | 29 | 0 |
| 1999 | 12 | 0 |
| 2000 | 12 | 0 |
| 2001 | 22 | 7 |
| 2002 | 20 | 30 |
| 2003 | 28 | 61 |
| 2004 | 14 | 61 |
| 2005 | 12 | 77 |
| 2006 | 23 | 90 |
| 2007 | 30 | 125 |
| 2008 | 29 | 103 |
| 2009 | 47 | 138 |
| 2010 | 60 | 161 |
| 2011 | 83 | 176 |
| 2012 | 61 | 146 |
| 2013 | 81 | 140 |
| 2014 | 73 | 130 |
| 2015 | 70 | 139 |
| 2016 | 72 | 138 |
| 2017 | 69 | 126 |
| 2018 | 68 | 130 |
| 2019 | 91 | 105 |
| 2020 | 47 | 96 |
| 2021 | 69 | 76 |
| 2022 | 42 | 90 |
| 2023 | 34 | 78 |
| 2024 | 33 | 60 |
| 2025 | 46 | 71 |
| 2026 | 36 | 60 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- G01N 2800/324Coronary artery diseasesIndexing code378
- G01N 2800/325Heart failure or cardiac arrestIndexing code320
- G01N 2800/323Arteriosclerosis, stenosisIndexing code281
- G01N 2800/321Arterial hypertensionIndexing code86
- G01N 2800/326ArrhythmiasIndexing code49
- G01N 2800/328Vasculitis, i.e. inflammation of blood vesselsIndexing code25
- G01N 2800/329Diseases of the aorta or its branchesIndexing code24
- G01N 2800/327EndocarditisIndexing code3
All 9 subgroupsShow fewer
Recent patents
- Single-cell morphology analysis for disease profiling and drug discovery6 Oct 2026US 12,755,831 B2Universität Heidelberg
- Galectin-3 immunoassay22 Sep 2026US 12,742,787 B2BG Medicine, Inc.
- Accurate and comprehensive cardiac troponin I assay enabled by nanotechnology and proteomics22 Sep 2026US 12,744,137 B2Wisconsin Alumni Research Foundation
- Methods for apolipoprotein detection15 Sep 2026US 12,736,545 B2Biocross, S.L.
- Pharmaceutical composition for lowering blood cholesterol, preventing or treating cardiovascular diseases and reducing inflammation25 Aug 2026US 12,715,899 B2Seoul National University Hospital
- Compositions and methods for treating diseases and conditions associated with activation of the nlrp3 inflammasome1 Oct 2026US 2026/0297180 A1
- Postural orthostatic tachycardia syndrome and crth224 Sep 2026US 2026/0287597 A1Amerimmune LLC
- Assessing and treating acute decompensated heart failure17 Sep 2026US 2026/0273021 A1Mayo Foundation for Medical Education and Research
- Methods for assessing platelet function17 Sep 2026US 2026/0276652 A1
- Methods of assessing metabolic health17 Sep 2026US 2026/0276661 A1Baker Heart and Diabetes Institute
Most cited
By later US patents
- Therapeutic inhibitor of vascular smooth muscle cells562US 5,733,925 ANeoRx Corporation · 1998
- Therapeutic inhibitor of vascular smooth muscle cells438US 5,981,568 ANeoRx Corporation · 1999
- Therapeutic inhibitor of vascular smooth muscle cells308US 6,074,659 ANoeRx Corporation · 2000
- Therapeutic inhibitor of vascular smooth muscle cells280US 5,811,447 ANeoRx Corporation · 1998
- Therapeutic inhibitor of vascular smooth muscle cells245US 6,171,609 B2NeoRx Corporation · 2001